A.I. Matesanz, P. Souza / Inorganic Chemistry Communications 27 (2013) 5–8
7
Scheme 2. Tautomeric forms of unsubstituted and monosubstituted thiosemicarbazones.
C\N and N\N bond distances are intermediate between formal single
References
and double bonds.
[1] T.S. Lobana, R. Sharma, G. Bawa, S. Khanna, Bonding and structure trends of
thiosemicarbazone derivatives of metals—an overview, Coord. Chem. Rev. 253
(2009) 977–1055.
[2] J.M. Vila, T. Pereira, A. Amoedo, M. Graña, J. Martínez, M. López-Torres, A.
Fernández, The key role of sulfur in thiosemicarbazone compounds. Crystal and
molecular structure of [Pd{4-MeOC6H4C(Me)_NN_C(S)NHPh}2], J. Organomet.
Chem. 623 (2001) 176–184.
[3] J.S. Casas, M.S. García-Tasende, J. Sordo, Main group metal complexes of
semicarbazones and thiosemicarbazones. A structural review, Coord. Chem. Rev.
209 (2000) 197–261.
[4] A.C. Sartorelli, K.C. Agrawal, A.S. Tsiftsoglou, E.C. Moore, Characterization of the
biochemical mechanism of action of α-(N)-heterocyclic carboxaldehyde
thiosemicarbazone, Adv. Enzym. Regul. (1977) 117–139.
Inspection of the angles formed between the platinum(II) ion and
the coordinated atoms shows that the metal is contained within a
slightly distorted square-planar environment. The distortion is caused
by the restricted bite angle of the N(4), N(3), S(1) donor set as reflected
in the S(1)\Pt(1)\N(3) and N(3)\Pt(1)\N(4) angles (less than 90°).
The angles N(4)\Pt(1)\N(6) and N(6)\Pt(1)\S(1) are therefore
greater than 90°.
The crystal structure is stabilized by intermolecular hydrogen in-
teraction involving the N(1) atom of the bidentate thiosemicarbazone
arm and the oxygen atom of the DMSO solvent molecule. Within each
molecule, the bis(thiosemicarbazone)-platinum moiety is close to
planar, so the supramolecular association also involves π–π stacking
interactions between parallel layers of molecules (Fig. 2).
[5] M.C. Liu, T.S. Lin, A.C. Sartorelli, Synthesis and antitumor-activity of amino derivatives of
pyridine-2-carboxaldehyde thiosemicarbazone, J. Med. Chem. 35 (1992) 3672–3677.
[6] R.A. Finch, M.C. Liu, A.H. Cory, J.G. Cory, A.C. Sartorelli, Triapine (3-aminopyridine-
2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase
with antineoplastic activity, Adv. Enzym. Regul. 39 (1999) 3–12.
[7] R.A. Finch, M.C. Liu, S.P. Grill, S.P.W.C. Rose, R. Loomis, K.M. Vasquez, Y.C. Cheng,
A.C. Sartorelli, Triapine (3-aminopyridine-2-carboxaldehydethiosemicarbazone):
a potent inhibitor of ribonucleotide reductase activity with broad spectrum
antitumor activity, Biochem. Pharmacol. 59 (2000) 983–991.
Acknowledgments
[8] A.I. Matesanz, I. Cuadrado, C. Pastor, P. Souza, A novel sulfur-bridged dimeric
zinc(II) complex with 2,6-diacetylpyridine bis(thiosemicarbazone), Z. Anorg.
Allg. Chem. 631 (2005) 780–784.
[9] A. Bino, N. Cohen, Several coordination modes of the pentadentate ligand
2,6-diacetylpyridinebis(thiosemicarbazone), Inorg. Chim. Acta 210 (1993) 11.
[10] M.R. Bermejo, A.M. Gonzlez-Noya, R.M. Pedrido, M.J. Romero, M. Vázquez, Route
to cluster helicates, Angew. Chem. 117 (2005) 4254–4259.
We are grateful to Ministerio de Economía y Competitividad,
Instituto de Salud Carlos III of Spain (PI080525 and PI1100659) for
financial support.
[11] M.R. Bermejo, A.M. González-Noya, M. Martínez-Calvo, R. Pedrido, M.J. Romero,
M. Vázquez, Checking the route to cluster helicates, Eur. J. Inorg. Chem. (2008)
3852–3863.
[12] P. Souza, A.I. Matesanz, C. Pastor, Preparation and structural characterisation of a
novel palladium(II) binuclear complex containing triazole bisthiosemicarbazone
bridges, Inorg. Chem. Commun. 5 (2002) 344–346.
[13] A.I. Matesanz, J. Mosa, I. García, C. Pastor, P. Souza, Synthesis, characterization,
crystal structure and electrochemistry of a novel palladium(II) binuclear complex
containing 1,2,4-triazole bis(4-phenylthiosemicarbazone) bridges, Inorg. Chem.
Commun. 7 (2004) 756–759.
[14] A.I. Matesanz, C. Pastor, P. Souza, Synthesis and structural characterization of a
disulphide-bridged tetranuclear palladium(II) complex derived from 3,5-diacetyl
1,2,4-triazole bis(4-ethylthiosemicarbazone), Inorg. Chem. Commun. 10 (2007)
97–100.
Appendix A. Supplementary material
Full crystallographic details have been deposited in CIF format
with the Cambridge Crystallographic Data Centre. CCDC 890162 con-
tains the supplementary crystallographic data for this paper. These
Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: +44 1223 336
[15] Ana I. Matesanz, Pilar Souza, Palladium and platinum 3,5-diacetyl-1,2,4-triazol
bis(thiosemicarbazones): chemistry, cytotoxic activity and structure–activity
relationships, J. Inorg. Biochem. 101 (2007) 245–253.
[16] A.I. Matesanz, C. Joie, P. Souza, Chemistry, antiproliferative activity and low nephro-
toxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their
platinum(II) complexes, Dalton Trans. 39 (2010) 7059–7065.
[17] A.I. Matesanz, C. Hernández, A. Rodríguez, P. Souza, Novel bis(thiosemicarbazones)
of the 3,5-diacetyl-1,2,4-triazol series and their platinum(II) complexes: chemistry,
antiproliferative activity and preliminary nephrotoxicity studies, Dalton Trans. 40
(2011) 5738–5745.
[18] A.I. Matesanz, C. Hernández, A. Rodríguez, P. Souza, 3,5-Diacetyl-1,2,4-triazol
bis(4N-substituted thiosemicarbazone) palladium(II) complexes: synthesis, structure,
antiproliferative activity and low toxicity on normal kidney cells, J. Inorg. Biochem.
105 (2011) 1613–1622.
[19] Ligand H2L1: Yield (73%). Anal. % found: C, 61.00; H, 5.55; N, 19.85; S, 12.90.
C
25H27N7S2 requires: C, 61.35; H, 5.50; N, 20.05; S, 13.10. MS(FAB+ with mNBA
matrix), m/z=490 for [H2L1+H]+. IR (KBr, cm−1), υ=3308, 3238, 3151 (s, NH);
υ=1589 (s, CN), υ=1520 (s, CN-thioamide I), υ=878 (m, CS-thioamide IV). 1H
NMR (300 MHz, d6-DMSO, ppm), δ=10.65 [s, N(2) and N(6), 2H]; 10.10 [s, N(1)
and N(7), 2H]; δ=8.55 [d, C(11) and C(13), 2H]; 7.75 [t, C(12), 1H]; δ=7.30–7.20
(m, aromatic-thiosemicarbazide, 8H); δ=2.50 (s, CH3-thiosemicarbazide, 6H);
δ=2.25 (s, CH3-diacetylpyridine, 6H).
[20] Complex [PtL1]: Yield (55%). Anal. % found: C, 42.35; H, 3.95, N, 13.00; S 12.25; C25H31-
N7PtS2·DMSO requires C, 42.45; H, 4.30, N, 12.85; S 12.60%. MS(FAB+ with mNBA ma-
trix), m/z=683 for [PtL1+H]+. IR (KBr, cm−1), υ=3353 (s, NH), υ=1586 (s, CN),
Fig. 2. View of platinum(II) complex [PtL2] showing the parallel disposition of the
molecules as a result of π–π stacking interactions.